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Objective. This series describes a developing experience in laparoscopic liver surgery presenting results from 40 procedures
including right hemihepatectomy, left lateral lobectomy, and microwave ablation therapy. Methods. Forty patients undergoing
laparoscopic liver surgery between September 1997 and November 2006 were included. The data set includes: operative procedure
and duration, intraoperative blood loss, conversion to open operation rates, length of hospital stay, complications, mortality,
histology of lesions/resection margins, and disease recurrence. Results. Mean age of patient: 59 years, 17/40 male, 23/40
female, 23/40 of lesions were benign, and 17/40 malignant. Operations included: laparoscopic anatomical resections n = 15,
nonanatomical resections n = 11, microwave ablations n = 8 and derooﬁng of cysts n = 7. Median anaesthetic time: 120 minutes
(range 40–240), mean blood loss 78mL and 1/40 conversions to open. Median resection margins were 10mm (range 1–14) and
median length of stay 3 days (range 1–10). Operative and 30-day mortality were zero with no local disease recurrence. Conclusion.
Laparoscopic liver surgery appears safe and eﬀective and is associated with reduced hospital stay. Larger studies are required to
conﬁrm it is oncologically sound.
Copyright © 2008 Laura Spencer et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Experience in laparoscopic liver surgery is growing world-
wide. This single centre series describes 40 laparoscopic
liver procedures carried out between September 1997
and November 2006. Included are both anatomical and
nonanatomical laparoscopic resections for both malignant
andbenigntumoursandnoveluseofthemicrowaveablation
probe on hepatocellular carcinoma and other benign lesions.
Operating times, resection margins, length of hospital stay,
amount of blood loss, and technical aspects of laparoscopic
liver surgery are discussed.
2. PATIENTS AND METHODS
Forty patients undergoing laparoscopic liver surgery by two
surgeons were identiﬁed from operating diaries between
September 1997 and November 2006. Information was gath-
ered on a standard proforma retrospectively from operating
notes, anaesthetic charts, histology reports, hospital notes,
hospital computer systems, general practitioner records, and
direct observation of procedures.
No patient was excluded and patients were selected
for laparoscopic surgery as having a lesion which was
technically possible to resect or treat laparoscopically whilst
leaving an adequate resection margin where applicable.
In the case of patients with hepatic tumours, a standard
multidisciplinary team approach in regards to preoperative
staging, treatment, and selection was adopted. Patients
selected for microwave ablation included: patients with HCC
who would not withstand formal liver resection due to
poor hepatic function, one patient undergoing laparoscopic
left lateral lobectomy for a suspicious lesion (at operation
suspected to be FNH), and a similar suspicious lesion in
segment 4a which was biopsied and then microwaved—
this prevented a major hemihepatectomy in a young patient
for benign disease, that is, an inaccessible haemangioma in
segment 7, and a metastasis from a parathyroid carcinoma2 HPB Surgery
in segment 4 preventing a major resection in a frail
patient.
Laparoscopicliversurgerywascarriedwithmostpatients
in a supine low Lloyd-Davies position, some right sided
lesions were accessed by positioning the patient on their
left side. One surgeon (DML) used an open approach for
obtaining a pneumoperitoneum for all candidates including
those who had had prior midline laparotomies. The second
surgeon (GSR) preferred to use a Veress needle inserted
at Palmer’s point (just below the left costal margin in
the midclavicular line), to insuﬄate the abdomen and
introduced a 5mm laparoscope in the left upper quadrant to
avoid any adhesions whilst introducing the umbilical trocar
inthosewithpriormidlinelaparotomies[1].Inpatientswith
no prior surgery, an open approach was used by GSR. A
thirty-degree laparoscope was used in all instances. Carbon
dioxide pressures were maintained between 8–12mmHg. In
general 5 ports including two 10/12 ports to interchange the
cavitronic ultrasound surgical aspirator (CUSA) (Valleylab
Tyco Healthcare, Boulder, Colo, USA) and camera were
used. No hand assistance was used. Resections were carried
out using the harmonic scalpel (Ethicon Endosurgery,
Cincinnati, Ohio, USA) or argon beam coagulator (Val-
leylab Tyco Healthcare) to cut through the capsule, and
CUSA for parenchymal dissection in conjunction with an
Allports vascular staple gun (Ethicon Endosurgery), or a
multiple clip applier for clipping vessels. The harmonic
scalpel uses ultrasonic energy vibrating at 55500Hz to allow
precise cutting and focussed coaptive coagulation allowing
preservation of important structures such as bile ducts and
larger blood vessels. Coaptive coagulation requires a lower
temperature (50◦C to 100◦C) than electrocautery or lasers
to denature proteins in the tissues forming a haemostatic
protein coagulum which seals smaller blood vessels, when
the eﬀect is prolonged, secondary heat is produced and
can seal larger vessels useful for fast eﬀective haemostasis
in laparoscopic hepatectomy. The argon beam coagulator
is useful in laparoscopic hepatectomy as it may coagulate
a large area such as the cut surface of the liver after
resection using lower temperatures (50◦C to 104◦C) than
standard electrocautery, thus minimising eschar and damage
to important structures such as bile ducts and large vessels.
A single Pringle manoeuvre was applied for 30 minutes
during the laparoscopic right hemihepatectomy, no other
resections required a Pringle manoeuvre and no outﬂow
control was necessary in any procedure. Intraoperative
ultrasound (BK Medical, Herlev, Denmark) was used to
assess extent of malignant tumours in all cases. At the end of
the resection, ﬁbrin glue (Johnson and Johnson, Cincinnati,
OH, USA) was used to seal the resection site. All tumours
were sealed in a retrieval pouch (Espiner Medical Limited
retrieval products, Bristol, UK) or an endocatch (Autosu-
tures,TycoHealthcare,Hampshire,UK)beforeremovalfrom
the abdomen. For microwave ablation (Microsulis Medicial
Limited, Hampshire, UK) the 5mm probe was inserted
through a laparoscopic port and the ceramic tip of the
probe inserted directly into the lesion, microwaves were then
radiated from the tip. Ablation progress was monitored by
real-time laparoscopic intraoperative ultrasound. At the end
of the operation, a tube drain is placed in the liver bed to
monitor any postoperative bile leaks. When derooﬁng large
liverandbileductcystsaportionofomentumissuturedinto
the defect to prevent bile leaks and a tube drain is again left
in situ for postoperative monitoring.
3. RESULTS AND DISCUSSION
Forty-three procedures including 41 laparoscopic liver pro-
cedures on 40 patients were performed between September
1997 and November 2006. The mean age of patient at opera-
tionwas59years,17/40ofpatientsweremaleand23/40were
female. The median American Society of Anaesthesiologist’s
(ASA) score was 2.
Malignant lesions resected were colorectal metastases.
Benign lesions treated included haemangiomas, liver cell
adenoma, focal nodular hyperplasia, and derooﬁng of liver
cysts and a bile duct cyst. Microwave ablation was utilised
for hepatocellular carcinoma, haemangioma, metastatic
parathyroidcarcinoma,andfocalnodularhyperplasia.Three
operations incorporated multiple procedures these included
a 74-year-old frail male patient who had a right inguinal
hernia repair immediately before proceeding to a planned
segment 5 resection of a colorectal metastasis. This negated
the requirement for a second anaesthetic. A 73-year-old male
who had a wedge excision of a haemangioma in segment
5 and microwave ablation of a second highly vascular
haemangiomainsegment6,minimisingtheamountoftissue
resectedforbenigndisease.A34-year-oldfemaleundergoing
laparoscopic left lateral lobectomy for a suspicious lesion
thought to be FNH, with a similar suspicious lesion found
in segment 4a, intraoperative frozen section conﬁrmed this
lesion also to be FNH and a successful microwave ablation
was performed preventing a formal hemihepatectomy in a
young patient with benign disease.
The operations included right hemihepatectomy n =
1, (a second right hemihepatectomy was aborted due
to widespread peritoneal disease following an exploratory
laparoscopy n = 1), left lateral lobectomy n = 4,
bisegmentectomy n = 2, segmetectomy n = 8, wedge
resection n = 11, microwave ablation n = 8, and derooﬁng
of liver and bile duct cysts n = 7, right inguinal hernia repair
n = 1.Table 1 describes thedemographic,intraoperative and
postoperative details of all the patients.
Median operating time for the entire group of patients as
judged by length of time under general anaesthetic in theatre
was 120 minutes (range 40–240 minutes). Mean blood
loss was 78mL and only one patient required transfusion.
Conversion to open operation was carried out in 1 out of
40 patients; this was a segment 5 resection for a colorectal
metastasis and was due to CUSA failure. There was no
perioperative mortality and no 30-day mortality. Median
total length of stay in hospital was 3 days. No bile leaks were
experienced and there were no other complications.
Median operating time excluding patients having only
cyst derooﬁng or microwave ablation, and excluding the
patient who was converted to open hepatectomy and the
patient having a failed right hemihepatectomy due to the
presence of peritoneal metastasis, was unchanged at 120Laura Spencer et al. 3
Table 1: Demographic, intraoperative, and postoperative details of patients undergoing laparoscopic liver surgery.
Patient Age Sex
Procedure Histology
Operation time Blood loss Resection margin Length of
Complications
(M/F) (minutes) (mL) (mm) stay (days)
16 3M RHH CRM 240 1500 1 4 Nil
26 0M WES3 HMG 240 0 CE 2 Nil
35 1 FWES5 LCA 120 0 CE 3 Nil
46 8 FS5/6R CRM 240 0 CE 5 Nil
57 4 FS4R CRM 180 0 22 3 Nil
66 9M S6R CRM 105 0 5 3 Nil
77 4M S5R+RIH CRM 180 0 CE 7 Nil
84 3 FS2R FNH 120 0 CE 3 Nil
97 5M S3R CRM 240 0 10 3 Nil
10 82 M LLB CRM 180 500 CE 4 Nil
11 77 M MAS4/8 HCC 150 0 CE 6 Nil
12 45 F WES6 HMG 180 0 45 6 Nil
13 64 M LLB CRM 240 0 10 4 Nil
14 73 M S6R CRM 240 600 4 6 Nil
15 73 M WES6, MAS5 HMG 90 0 CE 4 Nil
16 70 M MAS4a HCC 90 0 N/A 7 Nil
17 69 M S5R CRM 210 500 CE 10 Nil
18 57 F WES5 HMG 120 0 CE 2
Convert to
open due to
CUSA failure
19 36 F LLB FNH 120 0 CE 3 Nil
20 34 F LLB,MAS4 FNH 120 0 CE 3 Nil
21 55 M MAS7 HMG 90 0 N/A 2 Nil
22 58 F WES3 SOC LC 90 0 CE 2 Nil
23 38 M EL: (Planned
RHH aborted)
CRM
Peritoneal
deposits
90 0 N/A 2 Nil
24 51 M WES2/3 HMG 120 0 CE 3 Nil
25 47 F WE2/3 Angiomyo-
leiyoma
60 0 CE 2 Nil
26 52 F WES3
Mucinous
cystaden-
oma
60 0 CE 1 Nil
27 62 F LDBDC, SOC
Biliary
cystaden-
oma
40 0 N/A 2 Nil
28 41 F LDLC LC 40 0 N/A 2 Nil
29 73 F LDLC LC 60 0 N/A 1 Nil
30 57 F LDBDC, SOC BDC 60 0 N/A 2 Nil
31 56 F LDLC, SOC LC 60 0 N/A 1 Nil
32 84 M S5R CRM 60 10 CE 1 Nil
33 42 F LDPCL LCPCL 30 0 N/A 3 Nil
34 79 M LDPCL LCPCL 60 0 N/A 3 Nil
35 71 F MAS4 HCC 40 0 N/A 2 Nil
36 32 F WES5/6 FNH 120 0 30 3 Nil
37 43 F MAS4
Parathyro-ID
carcinoma
metastasis
60 0 N/A 1 Nil
38 51 F WES6 HMG 120 0 20 3 Nil
39 72 F S4/S6R CRM 200 0 4 3 Nil
40 34 F MA FNH 130 0 N/A 2 Nil4 HPB Surgery
Table 2
All patients
(including resections,
ablations, and cyst
derooﬁngs) N = 40
Patients undergoing
only laparoscopic
hepatectomy N = 25
Median
operation time
(minutes)
120 120
Mean blood loss
(mL) 78 104
Median length
of stay (days) 33
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Figure 1: Graph showing the number of laparoscopic liver proce-
dures per year 1997-2006.
minutes (range 60–240 minutes), mean blood loss was
104 mL, and median length of stay remained 3 days for this
group. This data is described in Table 2.
Median resection margins given by the pathologist were
10mm (range 1–45mm), where actual resection margins
were not given malignant lesions were described as com-
pletely excised (CE). Of the 17 malignant tumours, one
patient has died of coronary artery disease and one patient
who had a segment 5 resection of colorectal liver metastasis
has developed lung metastases. No patient has had locally
recurrent disease.
4. DISCUSSION
The beneﬁts and indications for laparoscopic liver surgery
have yet to be fully established. The ﬁrst reported laparo-
scopic liver resection was undertaken in 1991 for a benign
lesion [2]. Since then data from a recent review suggests that
most laparoscopic resections have been nonanatomical or
simple wedge resections or cyst fenestration and derooﬁng
forlivercysts[3].Leftlaterallobectomy(Couinaudsegments
2 and 3) has been carried out and also more rarely formal
left or right hemihepatectomy [4]. Approximately 70% of
resections have been carried out for benign lesions and
30% malignant lesions [5]. The largest series reports 100
resections [6].
Laparoscopic liver surgery is a developing ﬁeld and our
experience and learning curve together with a discussion
pertaining to indications, safety, and eﬃcacy of laparoscopic
hepatic resection and technical aspects of the surgery is
presented.
The ﬁrst laparoscopic liver resection at our institution
was a left lateral lobectomy in 1997 for focal nodular
hyperplasia. Since then the number of hepatic resections
carried out laparoscopically has increased year on year see
Figure 1.
Lesions selected for laparoscopic resection at our institu-
tionareintheeasilyaccessiblesegments:2,3,4a,5,and6well
away from the major hepatic veins. These lesions are often
visible on the liver surface and well characterised by saggital
andcoronalmagneticresonanceimages.Initiallyonlybenign
lesions were resected due to concerns regarding oncological
adequacy of laparoscopic resection margins and the risk of
tumour seeding in the port sites. The publication of the
conventional versus laparoscopic-assisted surgery in patients
with colorectal cancer (CLASICC) trial veriﬁed that there
were no signiﬁcant diﬀerences between open surgery and
laparoscopic-assistedcolorectaltumourexcisionwithrespect
to tumour and nodal status, therefore, laparoscopic surgery
in relation to excision of malignant hepatic tumours seemed
justiﬁed [7].
Microwave ablation has been under investigation by the
authors for the treatment of liver tumours in both animal
models and human patients [8–10]. The indications for the
use of microwave ablation are, as yet, not clearly deﬁned
thoughpatientswithHCCwhocouldnotwithstandaformal
hepatectomy due to loss of hepatic tissue, symptomatic
benign tumours (excluding liver cell adenoma), unusual
single liver tumours, and patients with tumour recurrence
in a liver that has previously undergone a resection are all
potential candidates and have been described in this series.
Controversy exists as to the adequacy of tumour exci-
sion and resection margin. One large seriesreports median
resection margins of 5 and 10mm for colorectal metastasis
and HCC, respectively [4]. Usage of the intraoperative ultra-
sound probe has been shown by Gigot et al. [11]t oi m p r o v e
adequacyofresectionmargin. Theintraoperative ultrasound
probe is therefore used routinely in our establishment when
resecting malignant tumours.
There are currently no randomised controlled trials
comparing open and laparoscopic hepatectomy but several
small nonrandomised comparative trials have suggested that
there is no diﬀerence in adequacy of resection margin
between open and laparoscopic hepatectomy [12–15]. The
medianresectionmarginformalignanttumoursinthisstudy
is 10mm and there has been no local recurrence. Recent
studies have now suggested that the width of a negative
resection margin does not aﬀect survival, recurrence risk, or
site of recurrence for colorectal metastasis [16]. It is of note
that anatomical resections for colorectal metastases have also
n o tb e e ns h o w nt ob es u p e r i o rt ow e d g er e s e c t i o n sa sl o n ga s
the tumour is clear at the resection margins [17].
Abdominalwallmetastasisatportsiteshasbeenreported
after laparoscopic surgery for malignant tumours [18].
Recent data has shown that there is no diﬀerence in wound-
site tumour recurrence between open and laparoscopic
colorectal surgery for if conventional oncological techniquesLaura Spencer et al. 5
suchasnotouchtechniqueandsealingresectedspecimensin
retrieval pouches before removal are employed, rates should
be less than 1% [19]. No wound site recurrence has been
experienced in this series to date.
Some surgeons have raised concerns for the possibility of
gas embolism due to transection of low pressure veins under
pneumoperitoneum. This has led some centres to adopt
a gasless laparoscopy technique, whereby intra-abdominal
space is created by abdominal suspension techniques [20].
Others have used a lower pressure carbon dioxide pneu-
moperitoneum, maintained between 10–12mmHg [4, 12].
Usage of the argon beam coagulator in both laparoscopic
cholecystectomy and laparoscopic liver surgery has been
associated with a clinical diagnosis of venous gas embolism
in several case reports [21–23]. A recent review suggests that
the incidence of clinical gas embolism in 700 laparoscopic
liver procedures carried out worldwide is reportedly 0.3%
[5]. It is, however, of interest that following laparoscopic
cholescystectomy intravascular gas bubbles have been rou-
tinely observed using transoesophageal echocardiography;
this does not seem to correlate with the clinical picture of
gas embolism [24].
An experimental study assessing the usage of argon-
enhanced coagulation of cut sections of liver in a porcine
model, whereby gas emboli were detected using a Doppler
ﬂow cuﬀ around the caudal vena cava, demonstrated that the
number of gas emboli produced increased with increasing
g a sﬂ o wr a t e sb u tw a sn o ta ﬀe c t e db yc o a g u l a t i o np o w e r .
This study recommended that surgeons and anaesthetists
shouldbeawarethatthereisapotentialtodevelopaclinically
important gas embolism and that adequate precautions
should be taken to prevent this such as selecting a low
ﬂow setting on the argon beam coagulator and adequate
venting of the abdomen through chimneys in laparoscopic
ports to maintain safe pressures of between 8–12mmHg
[25]. These measures have been adopted at our institution
where argon gas ﬂow is set to 4L/min (low ﬂow) on the
laparoscopic setting which incorporates an alarm if intra-
abdominal pressures exceed preselected limits—12mmHg
for laparoscopic hepatectomy which alerts the surgeon who
can open the port chimney to vent the abdomen. No clinical
signsofgasembolismhavebeenobservedinassociationwith
the argon beam coagulator. Hepatectomy can be associated
with severe haemorrhage and a major concern to some
is the threat of uncontrollable haemorrhage with minimal
access to the abdomen. This series presents an extremely low
operative blood loss rate with a mean blood loss of 78mL. It
is worthwhile noting that where laparoscopic liver resections
are converted to open procedures it is often due to bleeding.
In general, some studies comparing laparoscopic versus
open procedures have demonstrated that the laparoscopic
approach may well be associated with less blood loss
than open equivalents [14, 26]. This observation may be
due to the tamponading eﬀect of a pneumoperitoneum
and the anaesthetists at our institution raise the central
venous pressure to between 7–10mmHg whilst the surgeons
decrease the carbon dioxide insuﬄation pressure at the
end of all laparoscopic liver procedures in order to assess
safely for haemostasis. Additional anaesthetic considerations
pertaining to laparoscopic liver surgery include initially
running a lower central venous pressure of 1-2mmHg to
decrease bleeding and placement of a central line for central
venous pressure monitoring, but an epidural is not required
as postoperative analgesia requirements are usually conﬁned
to oral preparations.
The ﬁnal consideration for safe laparoscopic surgery
pertains to technical ability and experience of the surgeon.
It is recommended by the specialist advisory committee to
theNationalInstituteofClinicalExcellencethatlaparoscopic
liver resections should only be carried out in specialist
centres and by those with advanced skills in hepatic resection
and laparoscopy [27]. It is also apparent that the lesions
most suitable for laparoscopic resection are those situated
in the left lateral and right anterior segments away from the
main hepatic veins this in turn reduces the risk of serious
haemorrhage.
In conclusion this series conﬁrms evidence already
publishedinsupportoflaparoscopicliverresections.Patients
experience a shorter hospital stay, minimal blood loss,
shorter operation time, and short-term data indicates equiv-
alent oncological results when compared with conventional
open hepatectomy. Randomised controlled trials assessing
the oncological eﬃcacy of laparoscopic and open hepatec-
tomy for selected lesions are indicated at this stage.
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